ADAlexandre F. DaSilva

Alexandre F. DaSilva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alexandre F. DaSilva has a total of 163 co-authors. Here are the top co-authors by number of shared publications:

  • Marcos Fabio DosSantos

    Laboratório de Morfogênese Celular (LMC), Instituto de Ciências Biomédicas (ICB), Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, Brazil

    19 shared publications
  • Thiago D. Nascimento

    Headache and Orofacial Pain Effort (H.O.P.E.) Laboratory, Department of Biologic and Materials Sciences & Prosthodontics University of Michigan School of Dentistry Ann Arbor Michigan USA

    17 shared publications
  • Dajung J. Kim

    Headache and Orofacial Pain Effort (H.O.P.E.) Laboratory, Department of Biologic and Materials Sciences & Prosthodontics, University of Michigan, Ann Arbor, MI, 48109, USA

    9 shared publications
  • Jon-Kar Zubieta

    Department of Psychiatry, Mass General Brigham, Newton-Wellesley Hospital, Newton, Massachusetts

    9 shared publications
  • Robert A. Koeppe

    Department of Radiology, University of Michigan, Ann Arbor, MI, 48109, USA

    8 shared publications
  • Thiago Dias Nascimento

    Headache and Orofacial Pain Effort (H.O.P.E.) Laboratory, Department of Biologic and Materials Sciences & Prosthodontics, University of Michigan School of Dentistry, Ann Arbor, MI, USA

    8 shared publications

Latest Publications

  • Open Access

    Explosive synchronization and high-dimensional connectivity in fibromyalgia: A brain network mechanism of chronic pain

    by Pangyu Joo, Tony E. Larkin, Noah Waller, Joseph Heckman, Mina Nielsen, Alexandre F. DaSilva, UnCheol Lee, Richard E. Harris

  • Open Access

    Kappa opioid receptor availability correlates with depressive symptom burden in chronic migraine: a preliminary investigation

    by Dajung J. Kim, Majid Saberi, Tanpreet Kaur, Xia Shao, Robert A. Koeppe, Peter J. H. Scott, Frank Porreca, Alexandre F. DaSilva

    Chronic pain is frequently accompanied by affective disturbances, yet the neurobiological mechanisms linking pain perception and affective vulnerability remain poorly understood. The kappa opioid receptor (KOR)/dynorphin system has emerged as a key modulator of nociceptive and affective processes, in part through regulation of dopamine signaling within mesocorticolimbic circuits. However, the role of KOR signaling to pain-related affect and functional integration in migraine has not been characterized. We measured KOR availability using positron emission tomography (PET) with [¹¹C]LY2795050, a selective KOR antagonist radioligand in 12 individuals with chronic migraine (CM; 11 F/1 M; 42.0 ± 15.1 years) and 11 healthy controls (HC; 9 F/2 M; 40.9 ± 17.0 years). PET scans included an early resting and late sustained thermal pain stimulus stress (STPTS) phase, with KOR availability quantified as non-displaceable binding potential (BPND). Group differences in KOR BPND were assessed using region-of-interest (ROI) and voxel-wise analyses focusing on corticolimbic regions. Resting-state functional MRI (rs-fMRI) was additionally acquired to explore ROI-to-ROI functional connectivity (rsFC) within predefined regions. Exploratory interaction analyses examined whether group moderated the relationship between KOR BPND and rsFC strength. Associations between KOR BPND and clinical measures of pain intensity and affective symptoms were assessed using Spearman's rho correlation. Compared with HC, individuals with CM showed significantly elevated KOR BPND in the left anterior insula and lateral orbitofrontal cortex, particularly during STPTS phase. Exploratory interaction analyses revealed a differential relationship between fronto-insular KOR BPND and rsFC between the anterior and posterior insula. In addition, higher fronto-insular KOR BPND was positively correlated with greater subclinical depressive symptom scores, which were predominantly in the minimal-to-mild range, in the CM group. These findings indicate altered fronto-insular KOR availability in individuals with CM and suggest that KOR signaling may contribute to affective symptom burden, even at subclinical levels. The observed associations between KOR availability and rs-fMRI measures warrant cautious interpretation and further investigation in larger samples.


  • Open Access

    Reduced brain entropy in migraine with partial restoration during attacks: A resting-state fMRI study

    by Majid Saberi, Dajung J Kim, Xiao-Su Hu, Alexandre F DaSilva

  • Open Access

    High-definition tDCS restores adaptable neural dynamics in migraine

    by Majid Saberi, Dajung J. Kim, Xiao-Su Hu, Alexandre F. DaSilva

  • Open Access

    Reduced brain entropy in migraine with partial restoration during attacks: a resting-state fMRI study

    by Majid Saberi, Dajung J Kim, Xiao-Su Hu, Alexandre F DaSilva

    Migraine is a prevalent and disabling neurological disorder, characterized by difficulties in regulating headache activity, sensory processing, and cognitive-emotional states. Brain entropy quantifies the complexity of neural dynamics, where reduced entropy may reflect diminished neural adaptability, but its assessment with fMRI in migraine remains limited. Here, we examined alterations in brain entropy and their associations with clinical burden, attack timing, and symptomatology. Resting-state fMRI data were acquired from adults with episodic migraine, chronic migraine, and healthy controls. Following standard preprocessing, voxel-wise sample entropy was computed, and group differences were assessed using ANCOVA with age and sex as covariates. Associations with clinical burden and symptom measures were examined within affected regions. In chronic migraine, attack timing-related changes in entropy were further explored, and the largest Lyapunov exponent (LLE) was estimated to characterize chaotic dynamics underlying attack-related complexity changes. Migraine patients showed reduced entropy in sensory, attentional, and default mode regions compared to controls, most pronounced in chronic migraine. Lower entropy correlated with greater headache frequency and longer illness duration. In chronic migraine, entropy relatively increased during attacks in multisensory integration regions and was associated with positive and elevated LLEs, indicating partially restored complexity with weakly chaotic dynamics. Patients experiencing phonophobia and nausea also exhibited increased entropy in multisensory and default mode regions. Our findings demonstrate widespread reductions in brain entropy in migraine, reflecting impaired neural adaptability, whereas attacks may transiently restore complexity partially through chaotic dynamics. These results advance understanding of migraine pathophysiology and highlight potential targets for therapeutic intervention. Highlights - Migraine is marked by reduced brain entropy across sensory, attentional and default mode regions, which correlates with disease burden. - Reduced entropy reflects constrained neural adaptability within affected regions. - Migraine attacks transiently restore entropy, suggesting partial recovery of neural adaptability. - Positive and elevated Lyapunov exponents indicate a shift toward weakly chaotic dynamics during attacks. - Symptoms such as phonophobia and nausea are linked to increased entropy in multisensory integration and default mode regions.

  • Open Access

    μ‐Opioid Receptor Dynamics in the Parameningeal Tissue During Migraine Attacks

    by Dajung J. Kim, Manyoel Lim, Thiago D. Nascimento, Frank Porreca, Robert A. Koeppe, Nouchine Hadjikhani, Alexandre F. DaSilva

    Objective: The possible impact of meningeal μ‐opioid receptor (μOR) binding in migraine remains unknown. This study investigated μOR availability in the cranial parameninges involved in migraine initiation via nociceptor activation. Methods: We used positron emission tomography with [ 11 C] carfentanil, and measured μOR availability in meninges and adjacent skull bone (parameningeal tissue [PMT]) under resting and sustained thermal pain threshold stress challenge conditions. μOR availability was compared between individuals with migraine in interictal and ictal phases and healthy controls. Furthermore, we examined the relationship between μOR availability and headache intensity, as well as the potential influence of sex on this measure. Results: A total of 36 patients with interictal episodic migraine (8 also assessed ictally), 7 patients with ictal chronic migraine, and 22 healthy controls were included in the analysis. Both the episodic migraine and chronic migraine groups showed lower μOR availability in the parietal PMT than healthy controls during the ictal resting phase. No significant differences were observed during the interictal phase. Exploratory analyses on the effects of sex indicated that both healthy women and migraine patients of both sexes showed lower μOR availability in the frontal PMT compared with healthy men in the ictal sustained thermal pain threshold stress condition. Furthermore, the interictal μOR availability in the frontal PMT was negatively associated with headache intensity in the preceding month. Interpretation: The observed variability in PMT μOR availability across the different cortical regions and migraine episodes, along with its association with pain intensity, underscores the critical role of extracerebral mechanisms in migraine pathophysiology. ANN NEUROL 2025;98:777–787


  • Exploring HD-tDCS Effect on μ-opioid Receptor and Pain Sensitivity in Temporomandibular Disorder: A Pilot Randomized Clinical Trial Study

    by Dajung J. Kim, Thiago D. Nascimento, Manyoel Lim, Theodora Danciu, Jon-Kar Zubieta, Peter J.H. Scott, Robert Koeppe, Niko Kaciroti, Alexandre F. DaSilva


  • Functional Magnetic Resonance Imaging Signal Variability Is Associated With Neuromodulation in Fibromyalgia

    by Manyoel Lim, Dajung J. Kim, Thiago D. Nascimento, Eric Ichesco, Chelsea Kaplan, Richard E. Harris, Alexandre F. DaSilva


  • Open Access

    Effect of High-Definition Transcranial Direct Current Stimulation on Headache Severity and Central μ-Opioid Receptor Availability in Episodic Migraine

    by Alexandre F DaSilva, Dajung J Kim, Manyoel Lim, Thiago D Nascimento, Peter Jh Scott, Yolanda R Smith, Robert A Koeppe, Jon-Kar Zubieta, Niko Kaciroti

    Objective: The current understanding of utilizing HD-tDCS as a targeted approach to improve headache attacks and modulate endogenous opioid systems in episodic migraine is relatively limited. This study aimed to determine whether high-definition transcranial direct current stimulation (HD-tDCS) over the primary motor cortex (M1) can improve clinical outcomes and endogenous μ-opioid receptor (μOR) availability for episodic migraineurs. Methods: In a randomized, double-blind, and sham-controlled trial, 25 patients completed 10-daily 20-min M1 HD-tDCS, repeated Positron Emission Tomography (PET) scans with a selective agonist for μOR. Twelve age- and sex-matched healthy controls participated in the baseline PET/MRI scan without neuromodulation. The primary endpoints were moderate-to-severe (M/S) headache days and responder rate (≥ 50% reduction on M/S headache days from baseline), and secondary endpoints included the presence of M/S headache intensity and the use of rescue medication over 1-month after treatment. Results: In a one-month follow-up, at initial analysis, both the active and sham groups exhibited no significant differences in their primary outcomes (M/S headache days and responder rates). Similarly, secondary outcomes (M/S headache intensity and the usage of rescue medication) also revealed no significant differences between the two groups. However, subsequent analyses showed that active M1 HD-tDCS, compared to sham, resulted in a more beneficial response predominantly in higher-frequency individuals (> 3 attacks/month), as demonstrated by the interaction between treatment indicator and baseline frequency of migraine attacks on the primary outcomes. These favorable outcomes were also confirmed for the secondary endpoints in higher-frequency patients. Active treatment also resulted in increased μOR concentration compared to sham in the limbic and descending pain modulatory pathway. Our exploratory mediation analysis suggests that the observed clinical efficacy of HD-tDCS in patients with higher-frequency conditions might be potentially mediated through an increase in μOR availability. Conclusion: The 10-daily M1 HD-tDCS can improve clinical outcomes in episodic migraineurs with a higher baseline frequency of migraine attacks (> 3 attacks/month). This improvement may be, in part, facilitated by the increase in the endogenous μOR availability. Clinical Trial Registration: www.ClinicalTrials.gov, identifier - NCT02964741.